About Reshape Biotech
Reshape Biotech is a company based in Kongens Lyngby (Denmark) founded in 2018 by Daniel Storgaard and Carl-Emil Gron.. Reshape Biotech has raised $29.23 million across 4 funding rounds from investors including FundersClub, 21st.BIO and Astanor. The company has 16 employees as of December 31, 2022. Reshape Biotech offers products and services including Ecosystem Discovery Platform, Imaging Device, and High-throughput Imaging Device. Reshape Biotech operates in a competitive market with competitors including Opentrons, Andrew Alliance, Transcriptic, MEGAROBO and Automata, among others.
- Headquarter Kongens Lyngby, Denmark
- Employees 16 as on 31 Dec, 2022
- Founders Daniel Storgaard, Carl-Emil Gron
-
Sectors
Industrial Goods & Manufacturing
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Reshape Aps
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$29.23 M (USD)
in 4 rounds
-
Latest Funding Round
$20 M (USD), Series A
Apr 09, 2024
-
Investors
FundersClub
& 9 more
-
Employee Count
16
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Reshape Biotech
Reshape Biotech offers a comprehensive portfolio of products and services, including Ecosystem Discovery Platform, Imaging Device, and High-throughput Imaging Device. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Captures and analyzes lab data for seamless sharing and insights.
Provides high-resolution plate imaging and incubation for experiments.
Enables scalable plate analysis and real-time data extraction.
Unlock access to complete
Funding Insights of Reshape Biotech
Reshape Biotech has successfully raised a total of $29.23M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $20 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $20.0M
-
First Round
First Round
(23 May 2021)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Series A - Reshape Biotech | Valuation | Astanor , R7 Partners |
|
| Feb, 2023 | Amount | Seed - Reshape Biotech | Valuation | ACME | |
| Jun, 2021 | Amount | Seed - Reshape Biotech | Valuation | Y Combinator |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Reshape Biotech
Reshape Biotech has secured backing from 10 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include FundersClub, 21st.BIO and Astanor. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Astanor is focused on transforming the agrifood system through investments.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital investments are made in critical industries.
|
Founded Year | Domain | Location | |
|
Early-stage investments are directed toward disruptive technologies and innovations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Reshape Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Reshape Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Reshape Biotech Comparisons
Competitors of Reshape Biotech
Reshape Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Opentrons, Andrew Alliance, Transcriptic, MEGAROBO and Automata, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pipetting robots for laboratory automation are developed.
|
|
| domain | founded_year | HQ Location |
Provider of automated liquid handling tools and software for scientific labs
|
|
| domain | founded_year | HQ Location |
Cloud-based robotic bio-lab services are delivered remotely for experiment execution.
|
|
| domain | founded_year | HQ Location |
Robotic solutions for industrial laboratory automation are provided by MEGAROBO.
|
|
| domain | founded_year | HQ Location |
Lab automation robots are provided for life sciences applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Reshape Biotech
Frequently Asked Questions about Reshape Biotech
When was Reshape Biotech founded?
Reshape Biotech was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Where is Reshape Biotech located?
Reshape Biotech is headquartered in Kongens Lyngby, Denmark. It is registered at Kongens Lyngby, Capital Region, Denmark.
Who is the current CEO of Reshape Biotech?
Carl-Emil Gron is the current CEO of Reshape Biotech. They have also founded this company.
Is Reshape Biotech a funded company?
Reshape Biotech is a funded company, having raised a total of $29.23M across 4 funding rounds to date. The company's 1st funding round was a Seed of $125K, raised on May 23, 2021.
How many employees does Reshape Biotech have?
As of Dec 31, 2022, the latest employee count at Reshape Biotech is 16.
What does Reshape Biotech do?
Reshape Biotech was founded in 2018 in Kongens Lyngby, Denmark, within the biotechnology sector. Automated imaging and incubation capabilities are delivered through a scalable robotic platform, supporting data-driven decisions in microbiology research and development laboratories. Routine tasks are streamlined to enable emphasis on advanced research and collaboration efforts. Operations are centered on enhancing efficiency in scientific workflows.
Who are the top competitors of Reshape Biotech?
Reshape Biotech's top competitors include Opentrons, Andrew Alliance and Automata.
What products or services does Reshape Biotech offer?
Reshape Biotech offers Ecosystem Discovery Platform, Imaging Device, and High-throughput Imaging Device.
Who are Reshape Biotech's investors?
Reshape Biotech has 10 investors. Key investors include FundersClub, 21st.BIO, Astanor, R7 Partners, and ACME Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.